Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine¶
Polack, F. P. (2020). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine, 383(27), 2603-2615.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Statistical Power
- The minimum clinically important difference (MCID)—the effect size below which treatment differences are not clinically meaningful—provides the effect-size assumption for power analysis
This sourcePfizer-BioNTech COVID-19 vaccine trial with event-driven power-based design and sequential analysis.
- The minimum clinically important difference (MCID)—the effect size below which treatment differences are not clinically meaningful—provides the effect-size assumption for power analysis
Verification¶
Does it exist? Not checked yet. This entry carries no identifier to resolve. It was extracted from the citation as written in the article, normalized, and deduplicated against the rest of the registry.
Does it back the claim? Not recorded. The single citation of this work carries no recorded support check.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:01fbba1abec6 · see in the full table